Yanlian Yang

2.2k total citations
82 papers, 1.8k citations indexed

About

Yanlian Yang is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Yanlian Yang has authored 82 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 27 papers in Oncology and 24 papers in Biomaterials. Recurrent topics in Yanlian Yang's work include Extracellular vesicles in disease (16 papers), Alzheimer's disease research and treatments (16 papers) and RNA Interference and Gene Delivery (12 papers). Yanlian Yang is often cited by papers focused on Extracellular vesicles in disease (16 papers), Alzheimer's disease research and treatments (16 papers) and RNA Interference and Gene Delivery (12 papers). Yanlian Yang collaborates with scholars based in China, United States and Germany. Yanlian Yang's co-authors include Chen Wang, Ling Zhu, Huayi Wang, Xiaocui Fang, Zhiyuan Hu, Qing You, Houqian Gao, Jingyi Liu, Chen Wang and Ping Li and has published in prestigious journals such as Journal of the American Chemical Society, Advanced Materials and SHILAP Revista de lepidopterología.

In The Last Decade

Yanlian Yang

80 papers receiving 1.7k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Yanlian Yang 786 592 376 332 330 82 1.8k
Yojiro Maehata 748 1.0× 454 0.8× 209 0.6× 371 1.1× 339 1.0× 32 1.9k
Shun Li 936 1.2× 853 1.4× 280 0.7× 347 1.0× 514 1.6× 61 2.2k
Jin Yan 1.1k 1.3× 620 1.0× 294 0.8× 494 1.5× 444 1.3× 87 2.1k
Anthony M. Davies 871 1.1× 572 1.0× 586 1.6× 381 1.1× 190 0.6× 51 2.3k
Takemi Tanaka 1.2k 1.5× 751 1.3× 405 1.1× 329 1.0× 692 2.1× 62 2.5k
Mathumai Kanapathipillai 629 0.8× 776 1.3× 183 0.5× 241 0.7× 493 1.5× 34 1.8k
Sean Marrache 749 1.0× 514 0.9× 350 0.9× 356 1.1× 351 1.1× 16 1.6k
Ziyang Cao 919 1.2× 1.1k 1.9× 398 1.1× 256 0.8× 519 1.6× 64 2.3k
Guiyang Hao 504 0.6× 311 0.5× 338 0.9× 308 0.9× 195 0.6× 52 1.7k
Hae Yun Nam 1.1k 1.4× 497 0.8× 271 0.7× 206 0.6× 835 2.5× 32 2.2k

Countries citing papers authored by Yanlian Yang

Since Specialization
Citations

This map shows the geographic impact of Yanlian Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanlian Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanlian Yang more than expected).

Fields of papers citing papers by Yanlian Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanlian Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanlian Yang. The network helps show where Yanlian Yang may publish in the future.

Co-authorship network of co-authors of Yanlian Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Yanlian Yang. A scholar is included among the top collaborators of Yanlian Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanlian Yang. Yanlian Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Dongqi, Xiaocui Fang, Ping Li, et al.. (2025). Immunochemotherapeutic nanoparticles inhibit cancer-promoting fibroblasts subtypes for pancreatic ductal adenocarcinoma. Nano Today. 62. 102709–102709. 2 indexed citations
3.
Liu, Jingyi, et al.. (2024). Ultrasound-nanovesicles interplay for theranostics. Advanced Drug Delivery Reviews. 205. 115176–115176. 15 indexed citations
4.
Liu, Jingyi, Qing You, Siyuan Ye, et al.. (2024). T lymphocyte-derived immunogenic hybrid nanovesicles for immunosuppression reversion and boosted photothermal immunotherapy. Nano Today. 55. 102148–102148. 13 indexed citations
5.
Wang, Ruonan, Shanshan Mo, Mingzhan Wang, et al.. (2024). Structural evolution of the conformational ensembles in peptide fibrillar aggregates. Materials Today Physics. 44. 101437–101437. 1 indexed citations
6.
Liu, Mingpeng, Wenjia Lai, Mengting Chen, et al.. (2023). Prominent enhancement of peptide-mediated targeting efficiency for human hepatocellular carcinomas with composition-engineered protein corona on gold nanoparticles. Colloids and Surfaces A Physicochemical and Engineering Aspects. 662. 131016–131016. 8 indexed citations
7.
Xue, Mengfei, Siyuan Ye, Xiaopeng Ma, et al.. (2022). Single-Vesicle Infrared Nanoscopy for Noninvasive Tumor Malignancy Diagnosis. Journal of the American Chemical Society. 144(44). 20278–20287. 24 indexed citations
8.
Ye, Siyuan, Qing You, Huayi Wang, et al.. (2022). Nanostructures and Nanotechnologies for the Detection of Extracellular Vesicle. Advanced Biology. 7(2). e2200201–e2200201. 8 indexed citations
9.
Zhang, Huan, Yingkun Guo, Ju Jiao, et al.. (2022). A hepatocyte-targeting nanoparticle for enhanced hepatobiliary magnetic resonance imaging. Nature Biomedical Engineering. 7(3). 221–235. 66 indexed citations
10.
Ge, Yangyang, Shilin Xu, Xiaocui Fang, et al.. (2022). Nanomicelles co-loading CXCR4 antagonist and doxorubicin combat the refractory acute myeloid leukemia. Pharmacological Research. 185. 106503–106503. 15 indexed citations
11.
Zhu, Ling, et al.. (2021). BSA–MnO2–SAL multifunctional nanoparticle-mediated M1 macrophages polarization for glioblastoma therapy. RSC Advances. 11(56). 35331–35341. 6 indexed citations
12.
Jiang, Shasha, Xiaoyang Wang, Bin Jiang, et al.. (2021). BCAR1 plays critical roles in the formation and immunoevasion of invasive circulating tumor cells in lung adenocarcinoma. International Journal of Biological Sciences. 17(10). 2461–2475. 9 indexed citations
13.
Jiang, Mei, Yu-Chen Lin, Xiaocui Fang, et al.. (2021). Enhancement of gold-nanocluster-mediated chemotherapeutic efficiency of cisplatin in lung cancer. Journal of Materials Chemistry B. 9(24). 4895–4905. 12 indexed citations
14.
Zhang, Kaiyue, Xiaocui Fang, Qing You, et al.. (2020). Novel peptide-directed liposomes for targeted combination therapy of breast tumors. Materials Advances. 1(9). 3483–3495. 3 indexed citations
15.
Li, Ping, Yonghai Feng, Dan Xia, et al.. (2020). Self-Assembled Peptide Nanofibrils Designed to Release Membrane-Lysing Antimicrobial Peptides. ACS Applied Bio Materials. 3(6). 3648–3655. 33 indexed citations
16.
Yu, Lanlan, et al.. (2020). Position‐coded multivalent peptide–peptide interactions revealed by tryptophan‐scanning mutagenesis. Journal of Peptide Science. 26(9). e3273–e3273. 5 indexed citations
17.
Yu, Lanlan, Robert L. Dupont, Yang Xu, et al.. (2020). Molecular recognition of human islet amyloid polypeptide assembly by selective oligomerization of thioflavin T. Science Advances. 6(32). eabc1449–eabc1449. 16 indexed citations
18.
19.
Gao, Houqian, Zijian Zhao, Iman Rostami, et al.. (2019). Improved tumor targeting and penetration by a dual-functional poly(amidoamine) dendrimer for the therapy of triple-negative breast cancer. Journal of Materials Chemistry B. 7(23). 3724–3736. 30 indexed citations
20.
Zhao, Zijian, Ling Zhu, Haiyun Li, et al.. (2016). Antiamyloidogenic Activity of Aβ42-Binding Peptoid in Modulating Amyloid Oligomerization. Small. 13(1). 1602857–1602857. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026